(3R,4R)-1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE,
477600-70-7,
cis-1-Benzyl-N,4-dimethylpiperidin-3-amine,
MFCD09475548,
477600-69-4,
A1-00088,
3-PIPERIDINAMINE, N,4-DIMETHYL-1-(PHENYLMETHYL)-, (3R,4R)-,
Tofacitinib Impurity F,
AK-29283,
Tofacitinib Impurity E,
SCHEMBL352022,
CTK4J0251,
DTXSID70659968,
NVKDDQBZODSEIN-OCCSQVGLSA-N,
QC-53,
KS-000007KV,
ANW-52419,
MFCD11978163,
ZINC34040492,
AKOS007930642,
AKOS015919918,
ACN-025193,
CB-1392,
CM14193,
DS-0688,
FCH2823482,
FS-2942,
LS30281,
PB32723,
AC-24272,
AJ-86665,
AN-28178,
BR-29283,
SC-20075,
AB0025048,
AB1006556,
AX8033740,
ST2414289,
TR-017553,
W6439,
A25786,
B-1329,
(3R,4R)-1-benzyl-N,4-dimethyl-3-piperidinamine,
(3R,4R)-1-benzyl-N,4-dimethyl-piperidin-3-amine,
J-504320,
(3R,4R)-(1-Benzyl-4-methylpiperidin-3-yl)-methylamine,
3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-, (3R,4R)-,
(3R,4R)-(1-BENZYL-4-METHYL-PIPERIDIN-3-YL)-METHYL-AMINE,
null,
C14H22N2,
1-benzyl-N,4-dimethylpiperidin-3-amine,
-1-Benzyl-N,4-dimethylpiperidin-3-amine,
(1-Benzyl-4-methyl-piperidin-3-yl)-methyl-amine,
(3S,4S)-1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE,
1354621-59-2,